{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:57:01Z","timestamp":1778914621318,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T00:00:00Z","timestamp":1552348800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Catholic University for Health and Allied Sciences","award":["None"],"award-info":[{"award-number":["None"]}]},{"name":"Wurzburg Foundation","award":["None"],"award-info":[{"award-number":["None"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-3876-8","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T14:03:38Z","timestamp":1552485818000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Schistosomiasis and HIV-1 viral load in HIV-infected outpatients with immunological failure in Tanzania: a case-control study"],"prefix":"10.1186","volume":"19","author":[{"given":"Peter","family":"Masikini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0300-902X","authenticated-orcid":false,"given":"Soledad","family":"Colombe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amon","family":"Marti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Desderius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia J.","family":"de Dood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul L. A. M.","family":"Corstjens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Govert J.","family":"van Dam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mwanaisha","family":"Seugendo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Kalluvya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer A.","family":"Downs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,12]]},"reference":[{"key":"3876_CR1","volume-title":"Schistosomiasis Fact Sheet","author":"World Health Organization","year":"2018","unstructured":"World Health Organization: Schistosomiasis Fact Sheet. 2018. \n                    http:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/schistosomiasis\n                    \n                  . Accessed 28 May 2018."},{"issue":"10","key":"3876_CR2","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1111\/tmi.12165","volume":"18","author":"MLN Mbah","year":"2013","unstructured":"Mbah MLN, Poolman EM, Drain PK, Coffee MP, van der Werf MJ, Galvani AP. HIV and Schistosoma haematobium prevalences correlate in sub-Saharan Africa. Tropical Med Int Health. 2013;18(10):1174\u20139.","journal-title":"Tropical Med Int Health"},{"issue":"9","key":"3876_CR3","doi-asserted-by":"publisher","first-page":"e0005968","DOI":"10.1371\/journal.pntd.0005968","volume":"11","author":"JA Downs","year":"2017","unstructured":"Downs JA, Dupnik KM, van Dam GJ, Urassa M, Lutonja P, Kornelis D, et al. Effects of schistosomiasis on susceptibility to HIV-1 infection and HIV-1 viral load at HIV-1 seroconversion: a nested case-control study. PLoS Negl Trop Dis. 2017;11(9):e0005968.","journal-title":"PLoS Negl Trop Dis"},{"key":"3876_CR4","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/01.aids.0000210614.45212.0a","volume":"20","author":"EF Kjetland","year":"2006","unstructured":"Kjetland EF, Ndhlovu PD, Gomo E, Mduluza T, Midzi N, Gwanzura L, et al. Association between genital schistosomiasis and HIV in rural Zimbabwean women. AIDS. 2006;20:593\u2013600.","journal-title":"AIDS"},{"key":"3876_CR5","doi-asserted-by":"publisher","first-page":"868","DOI":"10.4269\/ajtmh.2012.12-0395","volume":"87","author":"JA Downs","year":"2012","unstructured":"Downs JA, van Dam GJ, Changalucha JM, Corstjens PLAM, Peck RN, de Dood CJ, et al. Association of schistosomiasis and HIV infection in Tanzania. Am J Trop Med Hyg. 2012;87:868\u201373.","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"3876_CR6","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.4269\/ajtmh.15-0652","volume":"94","author":"PH Brodish","year":"2016","unstructured":"Brodish PH, Singh K. Association between schistosoma haematobium exposure and human immunodeficiency virus infection among females in Mozambique. Am J Trop Med Hyg. 2016;94(5):1040\u20134.","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"3876_CR7","first-page":"856","volume":"96","author":"JA Downs","year":"2017","unstructured":"Downs JA, de Dood CJ, Dee HE, McGeehan M, Khan H, Marenga A, et al. Schistosomiasis and human immunodeficiency virus in men in Tanzania. Am J Trop Med Hyg. 2017;96(4):856\u201362.","journal-title":"Am J Trop Med Hyg"},{"issue":"7","key":"3876_CR8","doi-asserted-by":"publisher","first-page":"e0006613","DOI":"10.1371\/journal.pntd.0006613","volume":"12","author":"S Colombe","year":"2018","unstructured":"Colombe S, Machemba R, Mtenga B, Lutonja P, Kalluvya SE, de Dood CJ, et al. Impact of schistosome infection on long-term HIV\/AIDS outcomes. PLoS Negl Trop Dis. 2018;12(7):e0006613. \n                    https:\/\/doi.org\/10.1371\/journal.pntd.0006613\n                    \n                  .","journal-title":"PLoS Negl Trop Dis"},{"key":"3876_CR9","volume-title":"UNAIDS DATA 2017","author":"UNAIDS","year":"2017","unstructured":"UNAIDS. UNAIDS DATA 2017. 2017. \n                    http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/20170720_Data_book_2017_en.pdf\n                    \n                  . Accessed 28 May 2018."},{"issue":"5","key":"3876_CR10","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1097\/QAI.0b013e318282a1a4","volume":"62","author":"L Efraim","year":"2013","unstructured":"Efraim L, Peck RN, Kalluvya SE, Kabangila R, Mazigo HD, Mpondo B, et al. Schistosomiasis and impaired response to antiretroviral therapy among HIV-infected patients in Tanzania. J Acquir Immune Defic Syndr. 2013;62(5):e153\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"16","key":"3876_CR11","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1097\/00002030-200011100-00004","volume":"14","author":"SD Lawn","year":"2000","unstructured":"Lawn SD, Karanja DM, Mwinzia P, Andove J, Colley DG, Folks TM, et al. The effect of treatment of schistosomiasis on blood plasma HIV-1 RNA concentration in coinfected individuals. AIDS. 2000;14(16):2437\u201343.","journal-title":"AIDS"},{"issue":"1","key":"3876_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0035-9203(03)90040-X","volume":"97","author":"AM Elliott","year":"2003","unstructured":"Elliott AM, Mawa PA, Joseph S, Namujju PB, Kizza M, Nakiyingi JS, et al. Associations between helminth infection and CD4+ T cell count, viral load and cytokine responses in HIV-1-infected Ugandan adults. Trans R Soc Trop Med Hyg. 2003;97(1):103\u20138.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"10","key":"3876_CR13","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1086\/425042","volume":"190","author":"M Brown","year":"2004","unstructured":"Brown M, Kizza M, Watera C, Quigley MA, Rowland S, Hughes P, et al. Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda. J Infect Dis. 2004;190(10):1869\u201379.","journal-title":"J Infect Dis"},{"issue":"10","key":"3876_CR14","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1086\/429668","volume":"191","author":"M Brown","year":"2005","unstructured":"Brown M, Mawa PA, Joseph S, Bukusuba J, Watera C, Whitworth JA, et al. Treatment of Schistosoma mansoni infection increases helminth-specific type 2 cytokine responses and HIV-1 loads in coinfected Ugandan adults. J Infect Dis. 2005;191(10):1648\u201357.","journal-title":"J Infect Dis"},{"issue":"11","key":"3876_CR15","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1086\/497696","volume":"192","author":"P Kallestrup","year":"2005","unstructured":"Kallestrup P, Zinyama R, Gomo E, Butterworth AE, Mudenge B, van Dam GJ, et al. Schistosomiasis and HIV-1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV-1 RNA load. J Infect Dis. 2005;192(11):1956\u201361.","journal-title":"J Infect Dis"},{"issue":"12","key":"3876_CR16","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1017\/S0031182011000357","volume":"138","author":"LR Sangar\u00e9","year":"2011","unstructured":"Sangar\u00e9 LR, Herrin BR, John-Stewart G, Walson JL. Species-specific treatment effects of helminth\/HIV-1 co-infection: a systematic review and meta-analysis. Parasitology. 2011;138(12):1546\u201358. \n                    https:\/\/doi.org\/10.1017\/S0031182011000357\n                    \n                  .","journal-title":"Parasitology"},{"issue":"12","key":"3876_CR17","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S1473-3099(12)70207-4","volume":"12","author":"J Walson","year":"2012","unstructured":"Walson J, Singa B, Sangar\u00e9 L, Naulikha J, Piper B, Richardson B, et al. Empiric deworming to delay HIV disease progression in adults with HIV who are ineligible for initiation of antiretroviral treatment (the HEAT study): a multi-site, randomised trial. Lancet Infect Dis. 2012;12(12):925\u201332.","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"3876_CR18","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1089\/AID.2015.0274","volume":"32","author":"AE Obuku","year":"2016","unstructured":"Obuku AE, Asiki G, Abaasa A, Ssonko I, Harari A, van Dam GJ, et al. Effect of Schistosoma mansoni infection on innate and HIV-1-specific T-cell immune responses in HIV-1-infected Ugandan fisher folk. AIDS Res Hum Retrovir. 2016;32(7):668\u201375. \n                    https:\/\/doi.org\/10.1089\/AID.2015.0274\n                    \n                  .","journal-title":"AIDS Res Hum Retrovir"},{"key":"3876_CR19","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.3389\/fimmu.2018.02005","volume":"9","author":"S Colombe","year":"2018","unstructured":"Colombe S, Corstjens PLAM, de Dood CJ, Miyaye M, Magawa RG, Mngara J, et al. HIV-1 viral loads are not elevated in individuals co-infected with Schistosoma spp. after adjustment for duration of HIV-1 infection. Front Immunol. 2018;9:2005.","journal-title":"Front Immunol"},{"issue":"3","key":"3876_CR20","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1371\/journal.pntd.0000102","volume":"1","author":"JL Walson","year":"2007","unstructured":"Walson JL, John-Stewart G. Treatment of helminth co-infection in individuals with HIV-1: a systematic review of the literature. PLoS Negl Trop Dis. 2007;1(3):e102.","journal-title":"PLoS Negl Trop Dis"},{"key":"3876_CR21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/1471-2334-11-244","volume":"11","author":"CN Menezes","year":"2011","unstructured":"Menezes CN, Maskew M, Sanne I, Crowther NJ, Raal FJ. A longitudinal study of stavudine-associated toxicities in a large cohort of South African HIV infected subjects. BMC Infect Dis. 2011;11:244.","journal-title":"BMC Infect Dis"},{"issue":"8","key":"3876_CR22","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.trstmh.2007.02.020","volume":"101","author":"J Griensven van","year":"2007","unstructured":"van Griensven J, De Naeyer L, Mushi T, Ubarijoro S, Gashumba D, Gazille C, et al. High prevalence of lipoatrophy among patients on stavudine-containing first-line antiretroviral therapy regimens in Rwanda. Trans R Soc Trop Med Hyg. 2007;101(8):793\u20138.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"14","key":"3876_CR23","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1017\/S0031182014000626","volume":"141","author":"PLAM Corstjens","year":"2014","unstructured":"Corstjens PLAM, De Dood CJ, Kornelis D, Fat EM, Wilson RA, Kariuki TM, et al. Tools for diagnosis, monitoring and screening of Schistosoma infections utilizing lateral-flow based assays and upconverting phosphor labels. Parasitology. 2014;141(14):1841\u201355. \n                    https:\/\/doi.org\/10.1017\/S0031182014000626\n                    \n                  .","journal-title":"Parasitology"},{"issue":"2","key":"3876_CR24","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.exppara.2013.06.017","volume":"135","author":"GJ Dam van","year":"2013","unstructured":"van Dam GJ, de Dood CJ, Lewis M, Deelder AM, van Lieshout L, Tanke HJ, et al. A robust dry reagent lateral flow assay for diagnosis of active schistosomiasis by detection of Schistosoma circulating anodic antigen. Exp Parasitol. 2013;135(2):274\u201382.","journal-title":"Exp Parasitol"},{"key":"3876_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-9-1","volume":"9","author":"BJ Ngowi","year":"2009","unstructured":"Ngowi BJ, Mfinanga SG, Bruun JN, Morkve O. Immunohaematological reference values in human immunodeficiency virus-negative adolescent and adults in rural northern Tanzania. BMC Inf Dis. 2009;9:1.","journal-title":"BMC Inf Dis"},{"key":"3876_CR26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.4172\/2157-7560.1000249","volume":"5","author":"ER Shao","year":"2014","unstructured":"Shao ER, Kifaro EG, Kimaro J, Mrema JG, Mwasamwaja AO, Kayandabila J, et al. HIV-1 diversity in Tanzania and its implication toward development of effective vaccines: a review article. J Vaccines Vaccin. 2014;5:249. \n                    https:\/\/doi.org\/10.4172\/2157-7560.1000249\n                    \n                  .","journal-title":"J Vaccines Vaccin"},{"issue":"8","key":"3876_CR27","doi-asserted-by":"publisher","first-page":"e23091","DOI":"10.1371\/journal.pone.0023091","volume":"6","author":"C Kasang","year":"2011","unstructured":"Kasang C, Kalluvya S, Majinge C, Stich A, Bodem J, Kongola G, et al. HIV drug resistance (HIVDR) in antiretroviral therapy-naive patients in Tanzania not eligible for WHO threshold HIVDR survey is dramatically high. PLoS One. 2011;6(8):e23091.","journal-title":"PLoS One"},{"issue":"2","key":"3876_CR28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/QAI.0b013e3181c98fc0","volume":"54","author":"N Kiwanuka","year":"2010","unstructured":"Kiwanuka N, Robb M, Laeyendecker O, Kigozi G, Wabwire-Mangen F, Makumbi FE, et al. HIV-1 viral subtype differences in the rate of CD4+ T-cell decline among HIV seroincident antiretroviral naive persons in Rakai district, Uganda. J Acquir Immune Defic Syndr. 2010;54(2):180\u20134.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"3876_CR29","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1089\/aid.2007.0317","volume":"24","author":"N Ndembi","year":"2008","unstructured":"Ndembi N, Lyagoba F, Nanteza B, Kushemererwa G, Serwanga J, Katongole-Mbidde E. Transmitted antiretroviral drug resistance surveillance among newly HIV type 1-diagnosed women attending an antenatal clinic in Entebbe, Uganda. AIDS Res Hum Retrovir. 2008;24(6):889\u201395.","journal-title":"AIDS Res Hum Retrovir"},{"key":"3876_CR30","volume-title":"Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach. 2010 revision","author":"WHO HIV\/AIDS program","year":"2010","unstructured":"WHO HIV\/AIDS program. Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach. 2010 revision. 2010. \n                    http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241599764_eng.pdf?ua=1\n                    \n                  . Access 28 May 2018."},{"issue":"3","key":"3876_CR31","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/QAD.0000000000000543","volume":"29","author":"JA Denison","year":"2015","unstructured":"Denison JA, Koole O, Tsui S, Menten J, Torpey K, van Praag E, et al. Incomplete adherence among treatment-experienced adults on antiretroviral therapy in Tanzania, Uganda and Zambia. AIDS. 2015;29(3):361\u201371. \n                    https:\/\/doi.org\/10.1097\/QAD.0000000000000543\n                    \n                  .","journal-title":"AIDS"},{"issue":"20","key":"3876_CR32","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.286.20.2560","volume":"286","author":"AN Phillips","year":"2001","unstructured":"Phillips AN, Staszewski S, Weber R, Kirk O, Francioli P, Miller V, et al. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA. 2001;286(20):2560\u20137.","journal-title":"JAMA"},{"issue":"12","key":"3876_CR33","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1089\/apc.2013.0263","volume":"27","author":"VC Marconi","year":"2013","unstructured":"Marconi VC, Wu B, Hampton J, Ord\u00f3\u00f1ez CE, Johnson BA, Singh D, et al. Early warning indicators for first-line virologic failure independent of adherence measures in a south African urban clinic. AIDS Patient Care STDs. 2013;27(12):657\u201368.","journal-title":"AIDS Patient Care STDs"},{"key":"3876_CR34","first-page":"122","volume":"15","author":"DH Evans","year":"2012","unstructured":"Evans DH, Maskew M, Fox M, McNamara L, MacPhail P, Mathews C, et al. CD4 criteria improves the sensitivity of a clinical algorithm developed to identify viral failure in HIV-positive patients on first-line antiretroviral therapy. J Int AIDS Soc. 2012;15:122\u20133.","journal-title":"J Int AIDS Soc"},{"issue":"4 Suppl 3","key":"3876_CR35","doi-asserted-by":"publisher","first-page":"19666","DOI":"10.7448\/IAS.17.4.19666","volume":"17","author":"ND Labhardt","year":"2014","unstructured":"Labhardt ND, Bader J, Ramoeletsi M, Kamele M, Lejone TI, Cheleboi M, et al. Clinical and socio-demographic predictors for virologic failure in rural Southern Africa : preliminary findings from CART-1. J Int AIDS Soc. 2014;17(4 Suppl 3):19666. \n                    https:\/\/doi.org\/10.7448\/IAS.17.4.19666\n                    \n                  .","journal-title":"J Int AIDS Soc"},{"issue":"5","key":"3876_CR36","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1177\/1545109711406733","volume":"11","author":"G Chalamilla","year":"2012","unstructured":"Chalamilla G, Hawkins C, Okuma J, Spiegelman D, Aveika A, Christian B, et al. Mortality and treatment failure among HIV-infected adults in Dar Es Salaam, Tanzania. J Int Assoc Physicians AIDS Care (Chic). 2012;11(5):296\u2013304.","journal-title":"J Int Assoc Physicians AIDS Care (Chic)"},{"key":"3876_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7448\/IAS.17.1.18646","volume":"17","author":"P Penot","year":"2014","unstructured":"Penot P, H\u00e9ma A, Bado G, Kabor\u00e9 F, Sor\u00e9 I, Sombi\u00e9 D, et al. The vulnerability of men to virologic failure during antiretroviral therapy in a public routine clinic in Burkina Faso. J Int AIDS Soc. 2014;17:1\u20137.","journal-title":"J Int AIDS Soc"},{"key":"3876_CR38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1758-2652-13-4","volume":"13","author":"PJ Easterbrook","year":"2010","unstructured":"Easterbrook PJ, Smith M, Mullen J, O\u2019Shea S, Chrystie I, de Ruiter A, et al. Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy. J Int AIDS Soc. 2010;13:4. \n                    https:\/\/doi.org\/10.1186\/1758-2652-13-4\n                    \n                  .","journal-title":"J Int AIDS Soc"},{"issue":"5 Pt 2","key":"3876_CR39","doi-asserted-by":"publisher","first-page":"55R","DOI":"10.1203\/PDR.0b013e31819dca03","volume":"65","author":"KK Singh","year":"2009","unstructured":"Singh KK, Spector SA. Host genetic determinants of HIV infection and disease progression in children. Pediatr Res. 2009;65(5 Pt 2):55R\u201363R. \n                    https:\/\/doi.org\/10.1203\/PDR.0b013e31819dca03\n                    \n                  .","journal-title":"Pediatr Res"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3876-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-3876-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3876-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T20:10:08Z","timestamp":1583871008000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-3876-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,12]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3876"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-3876-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,12]]},"assertion":[{"value":"4 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants were recruited after providing written informed consent. Clearance was obtained from the joint CUHAS\/BMC Research Ethics Committee [CREC\/037\/2014]. All results were made available immediately to clinicians and recorded in the patient\u2019s medical record. All patients with schistosome infection received praziquantel 40\u2009mg\/kg in one dose on one single day.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"249"}}